Dynamic alteration in SULmax predicts early pathological tumor response and short-term prognosis in non-small cell lung cancer treated with neoadjuvant immunochemotherapy.
Sun T, Huang S, Jiang Y, Yuan H, Wu J, Liu C, Zhang X, Tang Y, Ben X, Tang J, Zhou H, Zhang D, Xie L, Chen G, Zhao Y, Wang S, Xu H, Qiao G.
Sun T, et al. Among authors: huang s.
Front Bioeng Biotechnol. 2022 Oct 6;10:1010672. doi: 10.3389/fbioe.2022.1010672. eCollection 2022.
Front Bioeng Biotechnol. 2022.
PMID: 36277407
Free PMC article.